dm+d

Unassigned

New Medicines

Eladynos (EU), Tymlos (US) Post-menopausal osteoporosis - transdermal patch

Information

Eladynos (EU), Tymlos (US)
New molecular entity
Radius Health
Radius Health

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

Novel synthetic peptide analog of human Parathyroid Hormone related Protein (hPTHrP) that is a bone anabolic compound with the potential to treat severe osteoporosis.
Osteoporosis affects 1 in 3 women over 50yrs of age.
Post-menopausal osteoporosis - transdermal patch
Transdermal

Eladynos (EU), Tymlos (US) Osteoporosis in men who are at high risk of fracture

Information

Eladynos (EU), Tymlos (US)
New molecular entity
Radius Health
Radius Health

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

Parathyroid hormone analogue
Approximately 20 percent of men over the age of 50 years will sustain an osteoporotic-related fracture in their lifetime attributed to multiple risk factors [1].
Osteoporosis in men who are at high risk of fracture
Subcutaneous injection